Woman, 9 months' pregnant, goes to hospital with severe headache.
A 34-year-old Illinois woman was 9 months' pregnant when she went to the hospital in 2003 complaining of a severe headache. She was admitted to labor and delivery and examined by an experienced L&D nurse and a second-year resident. The patient was diagnosed with preeclampsia, and lab tests showed HELLP syndrome. The hospital policy required administrating labetalol every 10 minutes in increasing doses until the blood pressure fell to a safe range. The patient received three doses of 10 mg each. Induction of labor was started but her blood pressure became critically elevated before delivery and she became unresponsive. An emergency cesarean section was performed and the infant was successfully delivered. A CT scan revealed that the woman had suffered a massive brain hemorrhage and she was placed on ventilator support. Four days later, the ventilator was disconnected, resulting in her death.
A lawsuit was filed on her behalf claiming negligence in the failure to control the patient's blood pressure according to the hospital policy, which ultimately resulted in her death.
The defense claimed that the preeclampsia and HELLP syndrome were so severe that she likely would not have survived in any event. A $22 million verdict was returned with both the physician and hospital found at fault.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More